ID-III: Antifungals Flashcards
Yeast
Candidida
Cryptococcus
Molds
Aspergillus
Zygomycetes
MOA Amphotericin B
Binds to ergosterol altering cell membrane permeability and causing cell death
Broad spectrum
Dimorphic fungi
Histoplasma
Blastomyces
Coccidiodes
What is the difference between Amp B deoxycholate and liposomal
Liposomal has less toxicity (decreased infusion reactions and nephrotoxicity)
BBW of Amphotericin B
Deoxycholate → cardiopulmonary arrest and death therefore should not exceed 1.5 mg/kg/d
ADR of Ampho B
Infusion-related: fever, chills, HA, malaise, rigors
↓ K, Mg and nephrotoxic
Describe premedication of Ampho B
Deoxycholate: requires premedication to reduce infusion-related reactions
Give 30-60 min prior to infusion:
- APAP or NSAID
- Diphenhydramine +/- hydrocortisone
- NS boluses to reduce nephrotoxicity
- +/- meperidine to reduce rigors
How should liposomal Ampho B be prepared?
D5W and must be filtered
Ampho B coverage
Yeast: Candida, Cryptococcus
Molds: Aspergillus and Zygomycetes
Dimorphic fungi: Histoplasma, Blastomyces, Coccidiodes
MOA of flucytosine
Converted to FU that competes with uracil and interferes with fungal RNA and protein synthesis
Flucytosine coverage
Combo with Ampho B due to increased resistance with mono therapy
Invasive cryptococcal or Candida
BBW of flucytosine
Renal dysfunction caution
ADR of flucytosine
Myelosuppression
Azole MOA
↓ ergosterol synthesis and cell membrane formation
Activity of fluconazole
C. albicans
C. parapsilosis
C. tropicalis
Fluconazole resistant strains
C. glabrata
C. krusei
Activity of itraconazole
Blastomyces and Histoplasma (nail bed infection)
Asperigillus treatment of choice
Voriconazole
BBW of itraconazole
HF, QTc prolongation, ventricular tacharrythmias due to DDI
Ketoconazole BBW
Hepatotoxity, QTc prolongation
ADR of azoles
LFTs, QTc prolongation
What treats fungal meningitis>
Fluconazole and voriconazole due to CNS penetration
Dose of vaginal candidiasis (fluconazole)
150 mg PO once